XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.40

+0.8%

9:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16403)	11/4/2003 8:31:39 AM
From: Robert K.	Read Replies (5) of 17367

Perhaps Blue. The dna/serono/xoma agreement calls for any on to do trials and each party having opt-in and opt-out clauses to each indication. It is possible that should dna or serono be agressive that xoma will have to ante-up to play. My guess is thought that dna will prod xoma for initial USA studies, then dna will take on P3s if looks good in P2. Of course xoma will have to pay for their share of P3's. I agree that that 100 mil plus might be designated a good portion for opt-ins. Also perhaps for that reason xoma will want to partner bpi-21 and let the partner run with it. Ditto for ING-1. I can see xoma running some of that 100 mil into other bpi's and R&D or manufactor expansion capabilities. skd, all imo, no facts ever.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next